These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1378652)

  • 1. Human vascular endothelial cells catabolise exogenous glycosaminoglycans by a novel route.
    Dawes J; Pepper DS
    Thromb Haemost; 1992 Apr; 67(4):468-72. PubMed ID: 1378652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells.
    Vischer P; Feitsma K; Schön P; Völker W
    Eur J Cell Biol; 1997 Aug; 73(4):332-43. PubMed ID: 9270876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin stimulates the synthesis and modifies the sulfation pattern of heparan sulfate proteoglycan from endothelial cells.
    Nader HB; Buonassisi V; Colburn P; Dietrich CP
    J Cell Physiol; 1989 Aug; 140(2):305-10. PubMed ID: 2745565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of heparin and other glycosaminoglycans on levels of tissue plasminogen activator and plasminogen activator inhibitor in cultured human umbilical vein endothelial cells.
    Marsh NA; Minter AJ; Chesterman CN
    Blood Coagul Fibrinolysis; 1990 Jun; 1(2):133-8. PubMed ID: 1966669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of interleukin 7 (IL-7) with glycosaminoglycans and its biological relevance.
    Clarke D; Katoh O; Gibbs RV; Griffiths SD; Gordon MY
    Cytokine; 1995 May; 7(4):325-30. PubMed ID: 8589262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of heparan sulfate moieties in cultured endothelial cells exposed to endotoxin.
    Colburn P; Dietrich CP; Buonassisi V
    Arch Biochem Biophys; 1996 Jan; 325(1):129-38. PubMed ID: 8554337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin and heparan sulfate binding sites on B-16 melanoma cells.
    Biswas C
    J Cell Physiol; 1988 Jul; 136(1):147-53. PubMed ID: 2840440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of heparan sulfate and its fractions with endothelial cells in culture.
    Tiozzo R; Cingi MR; Croce MA
    Int J Tissue React; 1993; 15(4):163-8. PubMed ID: 8188456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of glycosaminoglycans on U-937 leukemia cell proliferation and differentiation: structure-function relationship.
    Volpi N; Petrini M; Conte A; Valentini P; Venturelli T; Bolognani L; Ronca G
    Exp Cell Res; 1994 Nov; 215(1):119-30. PubMed ID: 7957660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basic fibroblast growth factor does not prevent heparan sulphate proteoglycan catabolism in intact cells, but it alters the distribution of the glycosaminoglycan degradation products.
    Tumova S; Hatch BA; Law DJ; Bame KJ
    Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):471-81. PubMed ID: 9895290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human recombinant interleukin-1 beta- and tumor necrosis factor alpha-mediated suppression of heparin-like compounds on cultured porcine aortic endothelial cells.
    Kobayashi M; Shimada K; Ozawa T
    J Cell Physiol; 1990 Sep; 144(3):383-90. PubMed ID: 2202741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific degradation of subendothelial matrix proteoglycans by brain-metastatic melanoma and brain endothelial cell heparanases.
    Marchetti D
    J Cell Physiol; 1997 Sep; 172(3):334-42. PubMed ID: 9284953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Murine macrophage heparanase: inhibition and comparison with metastatic tumor cells.
    Savion N; Disatnik MH; Nevo Z
    J Cell Physiol; 1987 Jan; 130(1):77-84. PubMed ID: 3805131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGFBP-3 and IGFBP-5 association with endothelial cells: role of C-terminal heparin binding domain.
    Booth BA; Boes M; Andress DL; Dake BL; Kiefer MC; Maack C; Linhardt RJ; Bar K; Caldwell EE; Weiler J
    Growth Regul; 1995 Mar; 5(1):1-17. PubMed ID: 7538367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of externally-disposed heparin/heparan sulfate binding sites by uterine epithelial cells.
    Wilson O; Jacobs AL; Stewart S; Carson DD
    J Cell Physiol; 1990 Apr; 143(1):60-7. PubMed ID: 2138625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decorin endocytosis: structural features of heparin and heparan sulphate oligosaccharides interfering with receptor binding and endocytosis.
    Hausser H; Kresse H
    Biochem J; 1999 Dec; 344 Pt 3(Pt 3):827-35. PubMed ID: 10585870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Heparan sulfate proteoglycan of endothelial cells: homocysteine suppresses anticoagulant active heparan sulfate in cultured endothelial cells].
    Nishinaga M; Shimada K
    Rinsho Byori; 1994 Apr; 42(4):340-5. PubMed ID: 8176841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosaminoglycan degradation fragments in mucopolysaccharidosis I.
    Fuller M; Meikle PJ; Hopwood JJ
    Glycobiology; 2004 May; 14(5):443-50. PubMed ID: 14718373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shedding of heparan sulfate proteoglycan by stimulated endothelial cells: evidence for proteolysis of cell-surface molecules.
    Ihrcke NS; Platt JL
    J Cell Physiol; 1996 Sep; 168(3):625-37. PubMed ID: 8816917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-associated proteoheparan sulfate mediates binding and uptake of thrombospondin in cultured porcine vascular endothelial cells.
    Schön P; Vischer P; Völker W; Schmidt A; Faber V
    Eur J Cell Biol; 1992 Dec; 59(2):329-39. PubMed ID: 1493798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.